As per MRFR analysis, the US Capsule Endoscopy Market Size was estimated at 117.6 (USD Million) in 2023. The US Capsule Endoscopy Market Industry is expected to grow from 127.4 (USD Million) in 2024 to 314.1 (USD Million) by 2035. The US Capsule Endoscopy Market CAGR (growth rate) is expected to be around 8.549% during the forecast period (2025 - 2035).
The US Capsule Endoscopy Market is experiencing notable trends driven by advancements in technology and an increase in the prevalence of gastrointestinal disorders. One of the main market drivers is the rising demand for non-invasive diagnostic procedures, as capsule endoscopy offers a less intrusive alternative to traditional endoscopic methods.
This shift is encouraged by both healthcare providers and patients seeking safer options, particularly for conditions like Crohn's disease and gastrointestinal bleeding. Opportunities are emerging for innovative capsule designs and improved imaging capabilities, as manufacturers focus on enhancing the diagnostic accuracy and comfort of these devices.
The growth of telemedicine in the US further supports these advancements, enabling better access to care and remote monitoring of patients using capsule endoscopy. Additionally, regulatory support from the FDA has facilitated quicker approvals for new capsule technologies, inviting more players to enter the market.
In recent times, an increasing emphasis on personalized healthcare in the US has also impacted the capsule endoscopy market. Healthcare providers are increasingly recommending this diagnostic tool because it can provide individualized insights into a patient's gastrointestinal health. Improvements in data analytics and integration with electronic health records are enhancing the value of capsule endoscopy, allowing for better patient management.
Furthermore, awareness campaigns about gastrointestinal diseases are helping to drive demand as more patients become informed and seek early diagnosis and treatment options. Overall, these trends indicate a promising future for the capsule endoscopy sector within the US healthcare landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The growing prevalence of gastrointestinal disorders such as Crohn's disease, ulcerative colitis, and gastrointestinal bleeding significantly drives the US Capsule Endoscopy Market Industry. According to the Centers for Disease Control and Prevention (CDC), gastrointestinal disorders affect millions of Americans, with conditions like Crohn's disease impacting approximately 780,000 individuals in the United States alone.
The rise in these cases necessitates advanced diagnostic techniques like capsule endoscopy, which provides a non-invasive solution. With the National Institute of Diabetes and Digestive and Kidney Diseases recommending capsule endoscopy as an effective diagnostic procedure for small bowel conditions, the demand for this technology is expected to increase, impacting market growth positively.
The ongoing focus of healthcare providers to improve diagnostic capabilities and ensure timely interventions further solidifies the role of capsule endoscopy in managing gastrointestinal issues effectively.
Technological innovations in capsule endoscopy systems contribute significantly to the growth of the US Capsule Endoscopy Market Industry. The development of high-definition imaging technology, improved battery life, and real-time data transmission features have made these devices more efficient. For instance, advancements in capsule design allow for enhanced visualization of gastrointestinal tract areas previously difficult to assess.
Research from the Food and Drug Administration (FDA) indicates that the approval of several high-tech capsule endoscopes in recent years demonstrates the commitment to cutting-edge solutions. As more healthcare institutions adopt these advanced technologies, the demand for capsule endoscopes will likely increase in the coming years.
Increased awareness and acceptance of capsule endoscopy as a viable diagnostic tool are essential drivers of the US Capsule Endoscopy Market Industry. Educational campaigns by organizations like the American Gastroenterological Association have made significant impacts, informing both healthcare professionals and patients about the benefits and effectiveness of capsule endoscopy.
A survey conducted by patient advocacy groups indicates that over 60% of individuals diagnosed with gastrointestinal disorders are open to discussing and trying new diagnostic procedures, including capsule endoscopy. This growing willingness among patients to pursue cutting-edge diagnostic techniques boosts market growth as more individuals seek out effective and non-invasive options for gastrointestinal testing.
The increase in healthcare expenditures and insurance coverage for advanced diagnostic procedures propels the US Capsule Endoscopy Market Industry forward. According to the American Hospital Association, U.S. health care spending rose by approximately 9.7% in a recent year, reflecting a growing investment in medical technologies, including capsule endoscopy.
Furthermore, insurance providers are expanding their coverage for capsule endoscopy procedures, recognizing their diagnostic importance and efficiency. The Centers for Medicare and Medicaid Services have been actively working to improve access to these innovative diagnostic tools, thereby encouraging more patients to opt for capsule endoscopy.
As a result, the synergy of rising healthcare costs and better insurance coverage translates to increased market growth prospects.
The US Capsule Endoscopy Market is witnessing substantial growth, driven by advancements in technology and increasing awareness of gastrointestinal disorders. The Product segment of the market is crucial, encompassing various devices pivotal to the diagnostic process. Capsule endoscopes are at the forefront, providing a non-invasive method for visualizing the small intestine and other areas that traditional endoscopy may not reach, which enhances patient comfort and diagnosis accuracy.
Within this segment, the small bowel focus is particularly significant, as conditions such as Crohn's disease and small bowel bleeding are increasingly prevalent among the population, contributing to a higher demand for innovative diagnostic solutions. The esophageal segment, addressing disorders like esophageal varices and strictures, has gained traction due to the rise in cases linked to lifestyle diseases, thus creating opportunities for expansive product development.
Moreover, the colon segment plays a critical role in cancer detection, given the rising incidence of colorectal cancer in the US, which underscores the necessity for effective screening technologies. Systems that integrate these devices with advanced imaging and data analysis capabilities are also emerging, enhancing workflow efficiency in healthcare settings.
The growing emphasis on early detection and non-invasive procedures is driving the growth of these products, making them vital components of the overall healthcare landscape. Key trends, such as the integration of artificial intelligence in reading endoscopic data and the development of more sophisticated capsule designs capable of capturing higher resolution images, further indicate a transformative phase within the US Capsule Endoscopy Market.
Collectively, these factors shape a dynamic ecosystem for the Product segment, presenting ample opportunities for innovation and growth in the years to come.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Capsule Endoscopy Market has experienced substantial growth in its Application segment, driven by an increasing prevalence of gastrointestinal disorders. Among the various conditions addressed by capsule endoscopy, OGIB (Obscure GI Tract Bleeding) is particularly significant, as it often presents diagnostic challenges and requires non-invasive solutions for effective management.
Crohn's Disease, a chronic inflammatory bowel condition, continues to gain attention due to rising incidence rates in the United States, emphasizing the need for advanced diagnostic tools like capsule endoscopy. The segment catering to Small Intestine Tumors is also crucial, given the complexities of early tumor detection in this area.
It reflects the ongoing advancements in medical technology to improve diagnostic accuracy and patient outcomes. Additionally, other applications within this market segment are expanding as healthcare providers seek innovative and minimally invasive solutions for various gastrointestinal disorders. These trends underscore the importance of capsule endoscopy as an essential diagnostic tool in the US healthcare landscape, aligning with broader efforts to enhance patient care and optimize treatment pathways.
The End-User segment of the US Capsule Endoscopy Market is fundamentally shaped by the diverse settings in which capsule endoscopy procedures are conducted. Hospitals hold a significant share as they offer advanced diagnostic facilities and comprehensive care, which is essential for effective patient management.
Ambulatory Surgery Centers are increasingly popular due to their ability to provide outpatient care, making the procedure more accessible for patients while reducing hospital-related expenses. The category of Others includes various healthcare settings, such as clinics and specialty facilities, which also contribute to the overall market by catering to specific patient needs.
The upward trend towards minimally invasive procedures and growing consumer awareness regarding gastrointestinal disorders are key drivers enhancing the adoption of capsule endoscopy across these end-users. Additionally, the increasing investment in healthcare infrastructure within the US facilitates the growth of this market segment, with hospitals and surgery centers focused on upgrading their technological capabilities.
The US Capsule Endoscopy Market statistics indicate a promising outlook, with relevance to various healthcare frameworks and patient care strategies.
The US Capsule Endoscopy Market is witnessing a dynamic competitive landscape characterized by rapid technological advancements and an increasing prevalence of gastrointestinal disorders. The market's growth is fueled by the rising need for non-invasive diagnostic procedures and the growing adoption of advanced medical technologies among healthcare providers.
Competitive insights reveal that companies within this space are focusing on developing innovative products that enhance diagnostic accuracy and patient comfort while reducing procedural time. Additionally, collaboration with healthcare facilities and expanding distribution networks are central strategies employed by key market players to strengthen their market position.
As the demand for capsule endoscopy continues to rise, the competitive arena is expected to become increasingly active, with companies striving to gain a competitive edge through differentiation and superior service offerings. CapsoVision has established itself as a significant player in the US Capsule Endoscopy Market by providing unique and effective solutions for gastrointestinal diagnosis.
The company is known for its innovative technology, which includes a cap-like device that offers a different approach to capsule endoscopy by freeing the patient from the complexities associated with traditional methods. This distinct technology underscores CapsoVision's commitment to improving patient experience and diagnostic capabilities.
Continuing to focus on research and development, CapsoVision invests in innovation to enhance its product line further and increase its therapeutic applications. With a growing market presence, CapsoVision stands out due to its strong emphasis on user-friendly systems and commitment to improving the standards of care in gastrointestinal diagnostics.
Wolf Medical Supply has made significant strides in the US Capsule Endoscopy Market by emphasizing quality and reliability in its products and services. The company operates as a distributor and supplier of various medical devices, including technology specifically designed for capsule endoscopy procedures.
The strengths of Wolf Medical Supply lie in its extensive market presence and strong relationships with healthcare providers, which enable the company to meet the evolving needs of the market effectively. The company offers a range of key products, enhancing the reliability of the diagnostic process while ensuring comprehensive support for healthcare facilities.
Wolf Medical Supply has also pursued strategic mergers and acquisitions to broaden its portfolio and enhance its competitive position within the US market. Its focus on delivering high-quality solutions and expanding its product offerings continues to reinforce its role in the ever-evolving arena of capsule endoscopy.
The US Capsule Endoscopy Market has seen notable developments recently, with CapsoVision, Medtronic, and Olympus Corporation leading advancements in technology and product offerings. In October 2023, Medtronic announced enhancements to its capsule system, improving diagnostic accuracy for gastrointestinal disorders.
Additionally, in August 2023, Boston Scientific reported an expansion in its capsule offerings, targeting increased accessibility in healthcare facilities across the US. In terms of mergers and acquisitions, Credo Medical acquired Given Imaging in September 2023, a move set to enhance their product portfolio and market presence, supported by multiple trusted news sources.
The market valuation for companies such as PillCam and SRS Medical has increased significantly, largely attributed to rising demand for minimally invasive diagnostic tools in the US healthcare system, which promotes faster recovery for patients. Over the past two to three years, the focus on technological improvements in capsule endoscopy has attracted investments, positioning this sector as a rapidly growing area within the healthcare market, driven by an increasing prevalence of gastrointestinal diseases nationwide.
Overall, these factors signal a dynamic and evolving landscape within the US Capsule Endoscopy Market.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 117.6(USD Million) |
| MARKET SIZE 2024 | 127.4(USD Million) |
| MARKET SIZE 2035 | 314.1(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.549% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | CapsoVision, Wolf Medical Supply, IntroMedic, Pepticore, Medtronic, Boston Scientific, Credo Medical, PillCam, Olympus Corporation, SRS Medical, Bain Medical, Roche, Given Imaging, Chongqing Jinshan Science and Technology, Sierra Scientific |
| SEGMENTS COVERED | Product, Application, End-User |
| KEY MARKET OPPORTUNITIES | Rise in gastrointestinal disorders, Technological advancements in imaging, Increasing awareness among patients, Growing demand for minimally invasive procedures, Expanding applications in diagnostics |
| KEY MARKET DYNAMICS | Technological advancements, Increasing prevalence of gastrointestinal disorders, Growing demand for minimally invasive procedures, Rising awareness and adoption rates, Supportive reimbursement policies |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Capsule Endoscopy Market is expected to be valued at 127.4 million USD in 2024.
The market is projected to reach 314.1 million USD by 2035.
The US Capsule Endoscopy Market is anticipated to grow at a CAGR of 8.549% from 2025 to 2035.
The Capsule Endoscopes segment is expected to hold a significant share, valued at 30.0 million USD in 2024.
The small bowel segment is expected to be valued at 40.0 million USD in 2024.
Major players include Medtronic, Boston Scientific, Olympus Corporation, and Given Imaging among others.
The esophageal segment is projected to reach 60.0 million USD by 2035.
The colon segment is expected to be valued at 22.4 million USD in 2024.
The market for capsule endoscopy systems is projected to reach 24.1 million USD by 2035.
Challenges include high costs and the need for advanced technology in the competitive landscape.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
